What are the Considerations in Balancing Benefits and Risks in Iron Treatment?: The Role for Newly Approved Iron Treatments.
Division of Nephrology, Department of Medicine, Hofstra Northwell Health School of Medicine, Great Neck, New York.
Steven
S
Fishbane
D061605:Administration, Intravenous; D000284:Administration, Oral; D018798:Anemia, Iron-Deficiency / Q000209:etiology* / Q000628:therapy*; D006801:Humans; D058085:Iron Compounds / Q000008:administration & dosage*; D051436:Renal Insufficiency, Chronic / Q000150:complications* / Q000628:therapy; D018570:Risk Assessment
D058085:Iron Compounds